Since FoxG1 is a lateral transcription factor, a gliogenic inhibitor, and negatively regulates Smads signaling, it is possible that FoxG1 is a mediator of TGF-β1 signaling in DMc. Here, TGFB1 is linked to Dyggve-Melchior-Clausen disease.